News Preview
AstraZeneca PLC (AZN) Presents at American Society for Bone and Mineral Research (ASBMR) 2026 Annual Meeting Transcript
AstraZeneca PLC (AZN) presented at the American Society for Bone and Mineral Research (ASBMR) 2026 Annual Meeting. The company discussed its pipeline and clinical data for its osteoporosis drug, AN650.
Want to stay up to date with the world events at sea or at home?
Explore Navvyx News - the best News app for seafarers.